Advertisement
Screener

AARDVARK THERAPEUTICS, INC. (AARD) Form D

AARDVARK THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-05-15: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-05-01; Total offering amount $84,999,982.
  • 2021-06-07: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-05-26; Total offering amount $30,000,000.
  • 2019-05-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-05-17; Total offering amount $15,000,007.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-05-15Rule 506(b)Equity2024-05-01$84,999,982$84,999,982$031
2021-06-07Rule 506(b)Equity2021-05-26$30,000,000$9,060,000$20,940,0008
2019-05-24Rule 506(b)Equity2019-05-17$15,000,007$9,000,003$6,000,00412

Similar stocks

Stock NameCountryMarket CapPE Ratio
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31